FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070708308> ?p ?o ?g. }

• W2070708308 endingPage "4417" @default.
• W2070708308 startingPage "4411" @default.
• W2070708308 abstract "Malignant gliomas are the most common of primary brain tumors and have been proven incurable with conventional treatments. Evidence have shown that a recombinant adenoviral vector expressing human wild-type p53, granulocyte-macrophage colony-stimulating factor (GM-CSF), and B7-1 genes (BB-102) may have antitumor effects in vitro. In this study, we investigated the effects of BB-102-based vaccine on glioma in vivo. An animal model using nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice with human immune system was established. The mice were vaccinated with inactivated U251 glioma cells transduced with BB-102 or adenoviral vector expressing green fluorescence protein (Ad-GFP) as a control and followed by the challenge of live U251 glioma cells. Tumor growth and antitumor responses were measured. Data showed that mice vaccinated with BB-102 had significantly reduced local tumor growth compared to mice with Ad-GFP vaccination or the control group. Histopathological analysis displayed low tumor cell density and significant infiltration of human peripheral blood lymphocytes (HuPBLs) in the tumor tissues of mice transduced with BB-102. Immunohistochemical analysis showed that mutant p53 was not expressed in tumor tissues of mice with BB-102 vaccination, and the expression level of Ki67 was significantly lower in the tumor tissues of the BB-102 group than those in the Ad-GFP group or the control group. Further study demonstrated that mice with BB-102 vaccination had significantly increased total T cell numbers, total T cell proportion, CD4+ T cell proportion, and CD8+ T cell proportion in spleens, as well as higher value of IgG, IgA, and IgE in sera. These data suggest that the recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes could suppress glioma in NOD/SCID mice model and might be considered as a novel strategy for glioma therapy." @default.
• W2070708308 created "2016-06-24" @default.
• W2070708308 creator A5001282484 @default.
• W2070708308 creator A5018120472 @default.
• W2070708308 creator A5022348147 @default.
• W2070708308 creator A5026169349 @default.
• W2070708308 creator A5050465904 @default.
• W2070708308 creator A5061239459 @default.
• W2070708308 creator A5062310871 @default.
• W2070708308 creator A5077404554 @default.
• W2070708308 date "2014-01-10" @default.
• W2070708308 modified "2023-09-27" @default.
• W2070708308 title "Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo" @default.
• W2070708308 cites W1567182449 @default.
• W2070708308 cites W1708153904 @default.
• W2070708308 cites W1963579401 @default.
• W2070708308 cites W1995587862 @default.
• W2070708308 cites W2007993961 @default.
• W2070708308 cites W2017519834 @default.
• W2070708308 cites W2019544994 @default.
• W2070708308 cites W2060277340 @default.
• W2070708308 cites W2075819066 @default.
• W2070708308 cites W2126229418 @default.
• W2070708308 cites W2133980633 @default.
• W2070708308 cites W2134807618 @default.
• W2070708308 cites W2138862343 @default.
• W2070708308 cites W2145625732 @default.
• W2070708308 cites W2147685974 @default.
• W2070708308 cites W2168159922 @default.
• W2070708308 doi "https://doi.org/10.1007/s13277-013-1580-7" @default.
• W2070708308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24408016" @default.
• W2070708308 hasPublicationYear "2014" @default.
• W2070708308 type Work @default.
• W2070708308 sameAs 2070708308 @default.
• W2070708308 citedByCount "0" @default.
• W2070708308 crossrefType "journal-article" @default.
• W2070708308 hasAuthorship W2070708308A5001282484 @default.
• W2070708308 hasAuthorship W2070708308A5018120472 @default.
• W2070708308 hasAuthorship W2070708308A5022348147 @default.
• W2070708308 hasAuthorship W2070708308A5026169349 @default.
• W2070708308 hasAuthorship W2070708308A5050465904 @default.
• W2070708308 hasAuthorship W2070708308A5061239459 @default.
• W2070708308 hasAuthorship W2070708308A5062310871 @default.
• W2070708308 hasAuthorship W2070708308A5077404554 @default.
• W2070708308 hasConcept C104317684 @default.
• W2070708308 hasConcept C111599444 @default.
• W2070708308 hasConcept C142613039 @default.
• W2070708308 hasConcept C150903083 @default.
• W2070708308 hasConcept C153911025 @default.
• W2070708308 hasConcept C167672396 @default.
• W2070708308 hasConcept C203014093 @default.
• W2070708308 hasConcept C207001950 @default.
• W2070708308 hasConcept C2778227246 @default.
• W2070708308 hasConcept C32470452 @default.
• W2070708308 hasConcept C40767141 @default.
• W2070708308 hasConcept C502942594 @default.
• W2070708308 hasConcept C55493867 @default.
• W2070708308 hasConcept C86803240 @default.
• W2070708308 hasConcept C8891405 @default.
• W2070708308 hasConceptScore W2070708308C104317684 @default.
• W2070708308 hasConceptScore W2070708308C111599444 @default.
• W2070708308 hasConceptScore W2070708308C142613039 @default.
• W2070708308 hasConceptScore W2070708308C150903083 @default.
• W2070708308 hasConceptScore W2070708308C153911025 @default.
• W2070708308 hasConceptScore W2070708308C167672396 @default.
• W2070708308 hasConceptScore W2070708308C203014093 @default.
• W2070708308 hasConceptScore W2070708308C207001950 @default.
• W2070708308 hasConceptScore W2070708308C2778227246 @default.
• W2070708308 hasConceptScore W2070708308C32470452 @default.
• W2070708308 hasConceptScore W2070708308C40767141 @default.
• W2070708308 hasConceptScore W2070708308C502942594 @default.
• W2070708308 hasConceptScore W2070708308C55493867 @default.
• W2070708308 hasConceptScore W2070708308C86803240 @default.
• W2070708308 hasConceptScore W2070708308C8891405 @default.
• W2070708308 hasIssue "5" @default.
• W2070708308 hasLocation W20707083081 @default.
• W2070708308 hasLocation W20707083082 @default.
• W2070708308 hasOpenAccess W2070708308 @default.
• W2070708308 hasPrimaryLocation W20707083081 @default.
• W2070708308 hasRelatedWork W2161230988 @default.
• W2070708308 hasRelatedWork W2298489141 @default.
• W2070708308 hasRelatedWork W2350510836 @default.
• W2070708308 hasRelatedWork W2357649990 @default.
• W2070708308 hasRelatedWork W2360372382 @default.
• W2070708308 hasRelatedWork W2361821711 @default.
• W2070708308 hasRelatedWork W2364889042 @default.
• W2070708308 hasRelatedWork W2370066866 @default.
• W2070708308 hasRelatedWork W2390364181 @default.
• W2070708308 hasRelatedWork W3143812318 @default.
• W2070708308 hasVolume "35" @default.
• W2070708308 isParatext "false" @default.
• W2070708308 isRetracted "false" @default.
• W2070708308 magId "2070708308" @default.
• W2070708308 workType "article" @default.